38
In band
Moving averages
SMA 200$467.58+7.43%
Company profile
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.
SectorHealthcare
IndustryBiotechnology
Market cap$130.56B
P/E ratio29.98
EPS$17.19
Beta0.32
Dividend yield0.00%
52-week high$560.25
52-week low$374.17
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 46
IOVA
Iovance Biotherapeutics Inc
RSI 66
MRNA
Moderna Inc
RSI 60
VKTX
Viking Therapeutics Inc
RSI 39
SRPT
Sarepta Therapeutics Inc
RSI 37
EDIT
Editas Medicine Inc
RSI 49
IBRX
ImmunityBio Inc
RSI 61
NVAX
Novavax Inc
RSI 60
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 63
RSI alerts for VRTX
Get an email the moment Vertex Pharmaceuticals Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 13 September 2026 at 1:55 AM EDT